Searchable abstracts of presentations at key conferences in endocrinology

ea0081p289 | Calcium and Bone | ECE2022

Hypercalcemia with positive calcium-sensing receptor (casr) autoantibodies

Vankemmel Romain , Dupuis Hippolyte , Herman Pierre-Loup , Fabien Nicole , Vantyghem Marie-Christine

CaSR-autoantibodies may cause auto-immune hypercalcemia through either simple blocking or biased properties. The phenotype of this rare disease is most often acquired hypocalciuric hypercalcemia (AAH) (Minanbres JCEM 2020, Makita JCI insight 2022), but sometimes hyperparathyroidism (Pelletier-Morel Intern Med 2008), in elderly. Gender, auto-immune context is variable. Blood calcium may fluctuate, and acute exacerbations may be successfully treated with predni...

ea0081ep759 | Pituitary and Neuroendocrinology | ECE2022

About two cases of adipsic hypernatremia in adults, one with proven blood antibodies against subfornical organ (SFOAb).

Charfi Lilia , Dupuis Hippolyte , Lucile Szuwarski , Christine Gillot , Akari Utsunomiya , Vantyghem Marie-Christine

Adipsic hypernatremia, a rare hypothalamic disorder characterized by a loss of thirst in response to hypernatremia is more often reported in children. An autoimmune mechanism has been recently demonstrated. We report two cases.Case1: A lean 67-year-old female, with a history of multilocular sclerosis, was admitted, for severe hypernatremia (162 mmol/l) with low ADH level (0.5 pmol/l; N: 0.5-2). She did not complain of thirst, despite ideomotor slowing an...

ea0067o20 | Oral Presentations | EYES2019

Phenotype of patients carrying the c.709(-7-2)del PRKAR1A mutation in a large cohort of 40 patients

Abderrahmane Fatimetou , Raverot Gerald , Lefebvre Herve , Cardot-Bauters Catherine , Vantyghem Marie-Christine , Bertherat Jerome , Espiard Stephanie

Objective: To describe the Carney Complex (CNC) manifestations presented by patients harboring the PRKAR1A mutation c.709(-7-2)del (one of the three hotspots) in a large cohort of patients.Methods: Multicenter retrospective study. Age at the diagnosis or at the screening of the different CNC manifestations is described by mean ± standard deviation.Results: Forty patients [12 index cases, 27 females, 46±15 years o...

ea0063oc6.4 | Obesity | ECE2019

Fat mass impact of sirolimus after clinical islet transplantation, a case control study

Jannin Arnaud , Espiard Stephanie , Hoth-Guechot Helene , Kerr-Conte Julie , Pattou Francois , Vantyghem Marie-Christine

Introduction: Sirolimus, a mTOR (mechanistic Target of Rapamycin) inhibitor, is well known for its impact on glucides and lipids metabolism. These effects vary according to factors such as dose and treatment duration, species, cell types and environmental factors. In vitro and in vivo, sirolimus inhibits adipogenesis by decreasing adipocytes number and size, as well as pre-adipocytes differentiation, leading to subcutaneous and visceral fat mass decrease in m...

ea0063gp151 | Interdisciplinary Endocrinology 1 | ECE2019

MEN4: is there a link with autoimmunity?

Chevalier Benjamin , Odou Marie-Francoise , Demonchy Jordane , Cardot-Bauters Catherine , Vantyghem Marie-Christine

MEN4 is a rare disease characterized by the development of multiple endocrine tumors caused by mutations in the CDKN1b gene encoding the cyclin dependent kinase inhibitor P27Kip1. Here we report two new cases and address the potential link of MEN4 with autoimmunity. The 1st patient, a 66-year old woman, presented at 35 years high prolactin levels without evidence of pituitary adenoma, treated medically. At 51 years, she was diagnosed with mild primary hyper...

ea0063p214 | Diabetes, Obesity and Metabolism 1 | ECE2019

Peroxisome proliferator activated receptor gamma mutation responsible for partial lipodystrophy with end stage renal disease: pharmacokinetics of metreleptine during hemodialysis: Clinical case report

Archambeaud Francoise , Vital Pauline , Galinat Sophie , Drutel Anne , Plas Camille , Vantyghem Marie Christine , Vigouroux Corinne

Lipodystrophy is a rare disorder characterised by loss of adipose tissue, severe insulin resistance, diabetes, hypertriglyceridemia, hepatic steatosis with hypoleptinemia. Renal complications are also present but end stage renal disease is less frequent in partial lipodystrophy. We report efficacy and pharmacokinetics of metreleptine during hemodialysis in one case of partial lipodystrophy. A caucasian female presented with acute pancreatitis, major hypertriglyceridemia (25 g/...

ea0049ep1369 | Thyroid (non-cancer) | ECE2017

Differential diagnosis between Anaplastic Thyroid Cancer and Primitive Lymphoma of the Thyroid gland: A 66-cases study

Kohler Florence , Vantyghem Marie-Christine , Carnaille Bruno , Leteurtre Emmanuelle , Boury Samuel , Terriou Louis , Do Cao Christine

A rapidly growing neoplastic mass of the neck can either be caused by an anaplastic thyroid cancer (ATC) or a primitive lymphoma of the thyroid gland (PLT). These two malignancies share the same clinical features but vary widely in their treatment and outcome. Only histologic criteria through biopsy can provide a definitive diagnosis. The aim of this study was to assess biological and radiological differences between ATC and PLT in order to hasten differential diagnosis. Sixty...

ea0041ep134b | Bone & Osteoporosis | ECE2016

Negative correlation of osteocalcin with insulin resistance, but not with body fat, in lamin-mutated lipodystrophies

Leclerc Marion , Benomar Kanza , Lion George , Douillard Claire , Vigouroux Corinne , Pigny Pascal , Vantyghem Marie-Christine

Bone is involved in both phosphate-calcium and energetic metabolism. Osteocalcin, secreted by the osteoblasts, stimulates insulin secretion and improves insulin sensitivity. FGF-23, secreted by the osteoclasts, increases phosphate urinary excretion and is a marker of insulin resistance. Relationship between insulin-resistance, body fat and bone metabolism remains unclear. Therefore, the aim of this study was to evaluate osteocalcin and FGF-23 levels in diseases differing by bo...

ea0037ep627 | Obesity and cardiovascular endocrinology | ECE2015

Irisin/leptin ratio, a biological marker of lean/fat mass, may help to identify LMNA-mutated familial partial lipodystrophies

Bensmaine Faiza , Mapihan Kristell Le , Bourry Samuel , Lion Georges , Vigouroux Corinne , Pigny Pascal , Vantyghem Marie Christine

Irisin is a myokine correlated with lean body mass, despite its association with cardiovascular events (Mantzoros 2014). Increased muscle volume and lipoatrophy have been reported in female FPLD (Ji JCEM 214). Our aim was to determine whether irisin could help to distinguish certain lipodystrophic obesities from FPLD.Methods and patients: Circulating irisin levels (EIA Phoenix) were measured in 20 LMNA-related FPLD, 19 normal-weighed controls (H) and 13 ...

ea0035oc11.3 | Diabetes and Obesity 2 | ECE2014

Improvement or stabilization of retinopathy and visual acuity after islet transplantation: a 5-year prospective study

Vantyghem Marie-Christine , Quintin Delphine , Labalette Pierre , Kerr-Conte Julie , Pattou Francois

This study describes the evolution of retinopathy 5 years after islet transplantation (IT) with the Edmonton protocol in type 1 diabetic patients. Before IT and then yearly for 5 years, 21 patients (13 islet-alone (ITA), 8 islet-after-kidney (IAK)) underwent monitoring of laboratory parameters, continuous 24 h mean blood pressure (24h BP) and 72 h glucose (CGM), as well as complete ophthalmologic examination. Ten of the 21 patients (48%) were insulin-independent 5 years post-I...